Biomarkers Aren’t Consistently Used to Select Participants for Immunotherapy Trials
Only a minority of clinical trials evaluating immunotherapeutic agents in 2019 used a biomarker to select patients for enrollment, a study found. The findings were reported at the virtual Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting & Preconference Programs (SITC 2020).
Clinical trials evaluated were listed on ClinicalTrials.gov between January 1, 2019, and December 31, 2019, and identified….Read More